Glow Blend 70mg (BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg)
Glow Blend 70mg is a multi-compound research peptide formulation supplied as a lyophilised vial for controlled analytical and in-vitro studies. This blend combines three research peptides — BPC-157, TB-500, and GHK-Cu — providing researchers the opportunity to examine complex peptide interactions, signalling pathways, and structural behaviour in multi-compound experimental models.
This batch has been tested for purity, confirming suitability for regulated laboratory environments.
-
Total content: 70mg
-
BPC-157 — 10mg
-
TB-500 — 10mg
-
GHK-Cu — 50mg
-
-
Lyophilised peptide blend in a sterile laboratory vial
-
Batch tested for purity (internal analytical verification)
-
Glow Blend is esigned for multi-compound pathway research
-
Research-grade production and handling standards
-
Stable formulation suitable for in-vitro and analytical studies
-
Secure, tamper-evident packaging
-
Multi-pathway cellular signalling studies
-
Regeneration-associated biological pathways
-
Cytoskeletal modelling and cell-migration behaviour
-
Copper-peptide interactions and structural pathway analysis (GHK-Cu)
-
Combined peptide response modelling under controlled conditions
-
Stability and degradation behaviour in multi-compound blends
-
Store at 2–8°C in a temperature-regulated environment
-
Protect from heat, moisture, and direct light
-
Keep sealed until laboratory analysis
-
Dispose of materials according to laboratory safety protocols
GHK-Cu (Copper Peptide) References
Pickart, L., & Margolina, A. (2018). GHK-Cu: An Overview of Biological Functions and Clinical Applications. Molecules, 23(7), 1417.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100036/
Maquart, F. X., et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu. FEBS Letters, 238(2), 343–346.
https://pubmed.ncbi.nlm.nih.gov/3140956/
Siméon, A., et al. (2000). Copper peptide GHK promotes wound healing and tissue remodeling. Journal of Cellular Biochemistry, 79(3), 423–434.
https://pubmed.ncbi.nlm.nih.gov/10972989/
BPC-157 References
Sikiric, P., et al. (1999). Stable gastric pentadecapeptide BPC 157: healing effects on gastrointestinal and systemic lesions. Journal of Physiology (Paris), 93(5), 217–226.
https://pubmed.ncbi.nlm.nih.gov/10652634/
Seiwerth, S., et al. (2014). BPC 157 and its effects on angiogenesis, nitric oxide pathways, and cytoprotection. Current Pharmaceutical Design, 20(7), 1121–1125.
https://pubmed.ncbi.nlm.nih.gov/23782145/
Vukojevic, J., et al. (2020). BPC-157 modulates inflammatory pathways and cellular repair mechanisms in preclinical models. Biomedicine & Pharmacotherapy, 132, 110798.
https://pubmed.ncbi.nlm.nih.gov/32971306/
TB-500 (Thymosin Beta-4 Fragment) References
Goldstein, A. L., et al. (2012). Thymosin beta-4: A multi-functional regenerative peptide. Annals of the New York Academy of Sciences, 1270(1), 84–89.
https://pubmed.ncbi.nlm.nih.gov/23002952/
Malinda, K. M., et al. (1997). Thymosin beta-4 stimulates directional migration of endothelial cells. FASEB Journal, 11(6), 474–481.
https://pubmed.ncbi.nlm.nih.gov/9194528/
Bock-Marquette, I., et al. (2004). Thymosin beta-4 activates integrin-linked kinase and promotes cell migration in vitro. Nature, 432(7016), 466–472.
https://pubmed.ncbi.nlm.nih.gov/15565156/
-
They are a legal adult (18+ years old).
-
The compound will be handled only by qualified professionals in controlled laboratory settings.
-
Use is restricted exclusively to lawful in-vitro research purposes.
-
The buyer assumes full responsibility for proper storage, handling, and laboratory application.
-
No warranties are provided beyond suitability for stated research use.
-
Phoenix Biolabs accepts no liability for misuse, misapplication, or unauthorised use.
Freya Morris –
Ordering was straightforward and the parcel arrived in excellent condition
Charlie Harrington –
Polite, knowledgeable staff; they answered my questions without rushing me